Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 3,500 | 0 | 68 | 0 | 1,000 |
| Cost of Goods | 1,575 | N/A | 100 | N/A | 350 |
| Gross Profit | 1,925 | N/A | -32 | N/A | 650 |
| Operating Expenses | 13,054 | 12,038 | 13,004 | 9,380 | 9,008 |
| Operating Income | -10,554 | -12,038 | -12,936 | -9,380 | -8,008 |
| Interest Expense | 103 | 101 | 178 | 157 | 200 |
| Other Income | -5,997 | 3,032 | 5,993 | 3,103 | 4,111 |
| Pre-tax Income | -16,654 | -9,107 | -7,121 | -6,434 | -4,097 |
| Net Income Continuous | -16,654 | -9,107 | -7,121 | -6,434 | -4,097 |
| Net Income | $-16,654 | $-9,107 | $-7,121 | $-6,434 | $-4,097 |
| EPS Basic Total Ops | -0.92 | -0.54 | 0.63 | -1.00 | -1.36 |
| EPS Basic Continuous Ops | -0.92 | -0.54 | 0.46 | -1.00 | -0.71 |
| EPS Diluted Total Ops | -0.92 | -0.54 | 0.63 | -1.00 | -1.36 |
| EPS Diluted Continuous Ops | -0.92 | -0.54 | 0.46 | -1.00 | -0.71 |
| EPS Diluted Before Non-Recurring Items | -0.44 | -0.54 | N/A | -1.48 | N/A |
| EBITDA(a) | $-9,716 | $-11,150 | $-11,927 | $-8,295 | $-6,638 |